Archer 3D Planning Software Cleared for Shoulder Arthroplasty

Catalyst OrthoScience Inc. (Catalyst) has received U.S. Food and Drug Administration 510(k) clearance to use the platform technology for its Archer 3D Targeting planning software in shoulder arthroplasty. Licensed in partnership with 3D-Shoulder, a subsidiary of 3D-Side, Archer 3D Targeting is a preoperative shoulder planning software encompassing both anatomic and reverse planning capabilities.

“We have been working with a group of design surgeons who have worked with Catalyst and 3D-Shoulder to develop the Archer 3D Targeting software,” said Carl O’Connell, CEO and president of Catalyst. “We are now initiating a limited user release with a controlled number of shoulder surgeons across the country who will test the software in clinical settings and provide us with feedback prior to a full commercial launch.”
 
Archer 3D Targeting equips shoulder surgeons with an advanced understanding of each patient’s unique pathology and delivers an individualized surgical plan prior to the procedure, with the ultimate goal of improving patient care. The software uses acquisition points such as the best fit sphere to initially place implants, which the surgeons can further refine within the plan.
 
“3D planning has completely changed my approach to planning for my shoulder arthroplasty cases,” said Matthew A. Kippe, M.D., sports medicine and shoulder surgeon with Hawthorn Medical Associates in North Dartmouth, Mass. “I can now better understand the deformity associated with certain arthritic conditions and more accurately place components in order to ensure better functional outcomes and perhaps improve longevity.”
 
“3D planning has become the gold standard for shoulder arthroplasty, and the addition of the Archer 3D Targeting software further expands Catalyst’s ability to offer solutions for surgeons and their patients,” said Joseph Gentile, M.D., orthopedic surgeon with Novant Health Orthopedics & Sports Medicine in Huntersville, N.C.
 
Catalyst OrthoScience, founded in 2014 by orthopedic surgeon Steven Goldberg, M.D., improves the patient and surgeon experience by making shoulder surgery less invasive and more efficient. The company has a portfolio of U.S. and international patents and pending patents on its distinctive surgical offerings. Headquartered in Naples, Fla., Catalyst products are available across the U.S. 
 
3D-Shoulder is a joint venture between 3D-Side, expert in cranioplasty and oncology surgery for more than 10 years and Jean-Marie Berger, a 20-year experienced executive in orthopedics, especially in shoulder arthroplasty. 3D-Shoulder has developed a specific vision on integrated surgical software dedicated to shoulder arthroplasty.